EMA Authorised: Zemcelpro (allogeneic umbilical cord-derived CD34- cells, non-expanded;dorocubicel) — Cordex Biologics International Limited

View source ↗

Summary

EMA authorized Zemcelpro, an allogeneic cord-derived CD34- cell therapy (dorocubicel), for hematologic neoplasms and hematopoietic stem cell transplantation, wi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hematologic Neoplasms

Drugs mentioned

• Zemcelpro

Snippet

Status: Authorised. Therapeutic area: Hematologic Neoplasms;Hematopoietic Stem Cell Transplantation. MAH: Cordex Biologics International Limited. Decision date: 17/02/2026. Conditional approval. Orphan medicine